Shopping Cart
Remove All
Your shopping cart is currently empty
Antitumor agent-212
Copy Product Info
🥰Excellent
Synonyms:
Catalog No. T219218 Copy Product Info
🥰Excellent
Antitumor agent-212 is a derivative of α-methyleneselenolactone, noted for its significant selective antitumor activity. It exhibits a minimum inhibitory concentration (MIC) of 128 μg/mL against Gram-positive bacteria. In the U87 human glioma xenograft model, Antitumor agent-212 demonstrates notable antitumor effects. This compound is applicable for research into glioma, breast cancer, non-small cell lung cancer, and antibacterial studies.
Antitumor agent-212
Cas No. 3108305-08-1
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Quotation
With extensive experience in compound synthesis, we can provide rapid custom synthesis services for this product according to your research needs.
For research use only—not for human use. No sales to individuals. Use as intended only.
Resource Download
Product Introduction
Bioactivity
Chemical Properties
Storage & Solubility Information
| Description | Antitumor agent-212 is a derivative of α-methyleneselenolactone, noted for its significant selective antitumor activity. It exhibits a minimum inhibitory concentration (MIC) of 128 μg/mL against Gram-positive bacteria. In the U87 human glioma xenograft model, Antitumor agent-212 demonstrates notable antitumor effects. This compound is applicable for research into glioma, breast cancer, non-small cell lung cancer, and antibacterial studies. |
| In vitro | Antitumor agent-212 (compound 2d) exhibits potent antiproliferative activity against U87 cells (IC 50 = 0.87 μM), C6 cells (IC 50 = 0.85 μM), 4T1 cells (IC 50 = 0.95 μM), and A549 cells (IC 50 = 1.32 μM) over a 72-hour period. It shows a selectivity index of 89.03 towards cancer cells, which is significantly higher than its effect on normal HEK293T cells (IC 50 = 77.15 μM). Additionally, Antitumor agent-212 has a minimum inhibitory concentration (MIC) of 128 μg/mL (302.6 μM) against Gram-positive Staphylococcus aureus and methicillin-resistant Staphylococcus aureus (MRSA), but demonstrates no activity against the Gram-negative bacterium Pseudomonas aeruginosa (MIC > 256 μg/mL). |
| In vivo | The compound Antitumor agent-212 (compound 2d), administered at 30 mg/kg via intraperitoneal (i.p.) and subcutaneous (S.C.) injections once daily for 15 days, demonstrated significant tumor growth inhibition without notable toxicity in a U87 human glioma xenograft model using male BALB/C nude mice. |
| Molecular Weight | 422.81 |
| Formula | C20H22ClNO2Se |
| Cas No. | 3108305-08-1 |
| Smiles | O=C1OC(C2=CC=C(Cl)C=C2)(C[Se]C=3C=CC=CC3)CC1CN(C)C |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, and a total of 10 animals are to be administered, using a formulation of 
10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.Stock Solution Preparation:
Dissolve 2 mg of the compound in 100 μL DMSO to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
Preparation of the In Vivo Formulation:
1) Add 100 μL of the DMSO stock solution to 400 µL PEG300 and mix thoroughly until the solution becomes clear.
2) Add 50 µL Tween 80 and mix well until fully clarified.
3) Add 450 µL Saline,PBS or ddH2O and mix thoroughly until a homogeneous solution is obtained.
This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: Antitumor agent-212 in vivo | Antitumor agent-212 in vitro | Antitumor agent-212 formula | Antitumor agent-212 molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.